Share this article
Share this article
ResearchAndMarkets.com s offering.
COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. The analyst has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the team on the fast-breaking events in the COVID-19 epidemic.
Particular sections address the most important market changes:
Molecular Diagnostics: COVID-19 has seen the molecular In Vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndrome tests, high throughput systems and surge production on badly needed kits.